0      0

The Journey from a Solid to a Biotech Production Site

Apr 25, 2022 2:30pm ‐ Apr 25, 2022 3:10pm

Credits: None available.


R-Pharm Germany has set up a biotechnical plant at its Illertissen site. Driven by the pandemic situation, a production area for vaccines and one for monoclonal antibodies (MAB) were established. In a very ambitious timeline, all the necessary infrastructure and supporting functions were also built.



Credits: None available.

You must be logged in and own this session in order to post comments.